Addex Therapeutics Ltd. Research And Development Expense

• Addex Therapeutics Ltd. showed a decrease of -28.0% in Research And Development Expense from 2023 to 2024.
• This data is from Addex Therapeutics Ltd.'s annual report (Form 10-K), filed with the SEC on May 15, 2025.
• XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2017 to 2024), Addex Therapeutics Ltd.'s Research And Development Expense has declined by 67.5%.
• Historical annual values: Fiscal year 2024: $854.3 thousand | Fiscal year 2023: $1.19 million | Fiscal year 2022: $8.24 million | Fiscal year 2021: $12.84 million | Fiscal year 2020: $10.37 million | Fiscal year 2019: $12.45 million | Fiscal year 2018: $4.92 million | Fiscal year 2017: $2.63 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026